1-hydroxy-3-amino-2-pyrrolidone has been researched along with Substance Withdrawal Syndrome in 4 studies
1-hydroxy-3-amino-2-pyrrolidone: a CNS depressant; structure in first source
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rabbani, M | 1 |
Wright, EJ | 1 |
Little, HJ | 1 |
Kosten, TA | 1 |
DeCaprio, JL | 1 |
Rosen, MI | 1 |
Bristow, LJ | 1 |
Hogg, JE | 1 |
Hutson, PH | 1 |
Christensen, D | 1 |
Guilbaud, G | 1 |
Kayser, V | 1 |
4 other studies available for 1-hydroxy-3-amino-2-pyrrolidone and Substance Withdrawal Syndrome
Article | Year |
---|---|
Tolerance to competitive NMDA antagonists, but no crosstolerance with barbiturates.
Topics: 2-Amino-5-phosphonovalerate; Animals; Ataxia; Behavior, Animal; Dizocilpine Maleate; Drug Tolerance; | 1995 |
The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist.
Topics: Animals; Anticonvulsants; Cycloserine; Excitatory Amino Acid Antagonists; Felbamate; Male; Morphine; | 1995 |
Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Behavior, Animal; Binding, Competitive; Clonidine | 1997 |
The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
Topics: Animals; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Morphine; Morphi | 2000 |